# Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC

> **NCT02200081** · PHASE2 · COMPLETED · sponsor: **Mologen AG** · enrollment: 103 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** MGN1703
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT02200081
- **Lead sponsor:** Mologen AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-11
- **Final completion:** 2017-10-05
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2018-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200081, "Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02200081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*